June 14 P&P Quick Takes: Washington state approved for subscription HCV model; plus Merck and IBM, BGI, and more

June 14 P&P Quick Takes: Washington state approved for subscription HCV model; plus Merck and IBM, BGI, and more

Source: 
BioCentury
snippet: 

Washington follows Louisiana in creating 'Netflix' model to buy HCV drugs
CMS approved Washington's Medicaid state plan amendment proposal to establish a subscription-based model for HCV drugs, under which the state would pay a fixed annual amount to a manufacturer for an unlimited supply of the medicine.